These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6499837)

  • 41. Humidifier fever and endotoxin exposure.
    Rylander R; Haglind P; Lundholm M; Mattsby I; Stenqvist K
    Clin Allergy; 1978 Sep; 8(5):511-6. PubMed ID: 709796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.
    Corvillo F; Bravo García-Morato M; Nozal P; Garrido S; Tortajada A; Rodríguez de Córdoba S; López-Trascasa M
    Clin Exp Immunol; 2016 Apr; 184(1):118-25. PubMed ID: 26660535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serological and clinical investigation of humidifier fever.
    McSharry C; Anderson K; Boyd G
    Clin Allergy; 1987 Jan; 17(1):15-22. PubMed ID: 3829367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350.
    Mold C; Bradt BM; Nemerow GR; Cooper NR
    J Immunol; 1988 Jun; 140(11):3867-74. PubMed ID: 2836501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Humidifier syndrome as occupational disease in Switzerland].
    Jost M; Lehmann M
    Schweiz Rundsch Med Prax; 1990 Jun; 79(25):797-803. PubMed ID: 2195621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of the alternative pathway of complement by Entamoeba histolytica.
    Ortiz-Ortiz L; Capin R; Capin NR; Sepúlveda B; Zamacona G
    Clin Exp Immunol; 1978 Oct; 34(1):10-8. PubMed ID: 219975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extrinsic allergic alveolitis caused by misting fountains.
    Koschel D; Stark W; Karmann F; Sennekamp J; Müller-Wening D
    Respir Med; 2005 Aug; 99(8):943-7. PubMed ID: 15950134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Biological characteristics and pathological significance of alternative pathway].
    Mikami A; Kohno M; Chimoto T
    Nihon Rinsho; 1979 May; 37(5):1011-6. PubMed ID: 381715
    [No Abstract]   [Full Text] [Related]  

  • 51. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Humidifier-associated disease in the general population].
    Müller-Wening D; Koschel D; Stark W; Sennekamp HJ
    Dtsch Med Wochenschr; 2006 Mar; 131(10):491-6. PubMed ID: 16511738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.
    Pier GB; Grout M; Desjardins D
    J Immunol; 1991 Sep; 147(6):1869-76. PubMed ID: 1832427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of the alternative pathway of human complement by the extracellular slime glycolipoprotein of Pseudomonas aeruginosa.
    Lambris J; Papamichail M; Ioannidis C; Dimitracopoulos G
    J Infect Dis; 1982 Jan; 145(1):78-82. PubMed ID: 6798132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The septic burned patient: a model for studying the role of complement and immunoglobulins in opsonization of opportunist micro-organisms.
    Bjornson AB; Altemeier WA; Bjornson HS
    Ann Surg; 1979 Apr; 189(4):515-27. PubMed ID: 109057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inherited deficiency of properdin and C2 in a patient with recurrent bacteremia.
    Gelfand EW; Rao CP; Minta JO; Ham T; Purkall DB; Ruddy S
    Am J Med; 1987 Mar; 82(3 Spec No):671-5. PubMed ID: 3826129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum complement levels before and after the onset of acute post-streptococcal glomerulonephritis. A case report.
    Strife CF; Forristal TJ; Forristal J
    Pediatr Nephrol; 1994 Apr; 8(2):214-5. PubMed ID: 8018502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation and characterization of rabbit properdin of the alternative complement pathway.
    Nakano Y; Matsuda T; Sakamoto T; Tomita M
    J Immunol Methods; 1986 Jun; 90(1):77-83. PubMed ID: 3635564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms of activation of the properdin system. Studies on properdin electrophoretic mobility in agarose activation of the alternative pathway.
    Adam C; Williams DG; Peters DK
    Clin Exp Immunol; 1975 Nov; 22(2):240-8. PubMed ID: 813932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abnormalities in the alternative pathway of complement in psoriasis.
    Marley WM; Belew PW; Rosenberg EW; Urmson JR; Stitzel AE; Spitzer RE
    Clin Exp Dermatol; 1982 Jul; 7(4):387-96. PubMed ID: 7127887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.